Meitheal Pharmaceuticals has gained FDA approval for GARZULYS, a rapid-acting insulin biosimilar, intensifying competition in a market historically dominated by originator products and few biosimilar entries. Meitheal Pharmaceuticals said on July 30, 2026 that the U.S. Food and Drug Administration…
The UK has authorised Eli Lilly’s Foundayo, a once-daily oral GLP-1 medication for weight management and type 2 diabetes, marking a significant development in accessible obesity treatments across Europe. The UK has become the first country in Europe to clear…
Eli Lilly’s shares rose nearly 4% after the UK’s MHRA approved Foundayo, its first weight-loss pill, marking a key milestone in the competitive obesity treatment market and granting the company a European foothold. Eli Lilly’s shares climbed nearly 4% on…
Egypt’s Health Ministry has responded to criticism over insulin imports, emphasising local manufacturing capabilities and distinguishing between brand shortages and overall drug availability to reassure diabetic patients amid ongoing debates on medicine imports. Egypt’s Health Ministry has moved to calm…
A Cleveland Clinic-led analysis uncovers ongoing challenges in tailoring diabetes treatment for seniors, showing many are not receiving appropriate adjustments based on blood-sugar levels and overall health status. A Cleveland Clinic-led analysis suggests many older adults with type 2 diabetes…
A study involving nearly 90,000 patients uncovers discrepancies between treatment changes and individualised glycaemic targets in older adults, raising concerns over overtreatment and undertreatment in diabetes management. Among older adults with type 2 diabetes, treatment changes often do not match…
Research from Cleveland Clinic shows many older adults with diabetes are not receiving treatment adjustments aligned with individualised HbA1c targets, risking both over- and under-treatment effects. In older adults with type 2 diabetes, most people whose HbA1c levels were outside…
Regular foot inspections, proper footwear, and glucose control are essential in preventing serious complications for individuals with type 1 diabetes, according to recent health guidance. Type 1 diabetes can quietly put the feet at risk long before a person feels…
Experts emphasise the importance of daily foot inspections, proper footwear, and regular clinical checks for people with type 1 diabetes to prevent silent damage and serious complications, even when no pain is present. Type 1 diabetes can quietly damage the…
South Korea’s National Institute of Health has developed an AI system that forecasts emergency room visits among type 2 diabetes patients, potentially enabling earlier intervention and reducing unnecessary hospitalisations. South Korea’s National Institute of Health has developed an artificial intelligence…
